INTELLIGENT BIO SOLUTIONS INC. (INBS) Form 424B3 — Sep 23, 2026
Intelligent Bio Solutions (INBS) filed a 424B3 prospectus registering 6,211,809 shares for resale by selling stockholders, including shares issuable upon exercise of warrants from the September 2026 private placement led by Alyeska Master Fund, L.P., with Ladenburg Thalmann acting as placement agent. The registered shares represent nearly 187% of the 3,316,803 shares outstanding as of September 14, 2026, creating substantial dilution and selling-pressure overhang. The company receives no proceeds from these resales, though a full cash exercise of the warrants would bring in roughly $9.82 million gross.
Key figures
- Gross Proceeds
- $5.0 million gross to company from private placement; ~$9.82 million potential if all warrants exercised for cash
- Offering Price
- $2.455 combined purchase price per share/pre-funded warrant plus accompanying warrants (September Private Placement)
- Shares Offered
- 6211809
- Shares Outstanding
- 3316803
- Placement agent fees
- 8.0% cash fee plus 1.0% management fee; 9.0% on warrant cash exercises
- Closing price sept 22 2026
- $1.80
- Other warrants outstanding
- 5223868
- Warrant exercise price N1 N2
- $2.33
- Pre funded warrant exercise price
- $0.01
- Other prefunded warrants outstanding
- 609425
- Placement agent expense reimbursement
- $60,000 paid at closing (up to $145,000)
- Warrant exercise price placement agent
- $3.06875
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.